YI Jilin

机构：Tongji Hospital, Huazhong University of Science and Technology

发表论文 14 篇 · 总被引 49 次 · h-index 2

代表论文

• Increased DJ-1 and its prognostic significance in hepatocellular carcinoma. (2011 · PubMed · 被引 30)
• Effects of BRAFV600E mutation on Na+/I- symporter expression in papillary thyroid carcinoma (2016 · Journal of Huazhong University of Science and Technology [Medical Sciences] · 被引 14)
• Efbemalenograstim Alfa, an Fc Fusion Protein, Long‑Acting Granulocyte Colony-Stimulating Factor for Reducing the Risk of Chemotherapy-Induced Neutropenia: Results of a Phase II Randomized, Multicenter, Open‑Label Trial (2025 · Clinical Drug Investigation · 被引 2)
• mRNA Expression of the Cancer-testis Antigens SSX1 and SSX4 in Human Hepatocellular Carcinomas (2004 · The Chinese-German Journal of Clinical Oncology · 被引 2)
• Effect of integrin β1 and tenascin on invasion and metastasis of hepatocellular carcinoma (2006 · World Chinese Journal of Digestology · 被引 1)
• Expression of PHD2 and HIF-1α in hepatocellular carcinoma and its clinical significance (2008 · Huazhong yixue zazhi)